Indel Therapeutics - discovering new drugs against infectious diseases

Indel Therapeutics Inc. is a biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs are based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that has opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.



September 11, 2012
Indel Therapeutics Named Industry Partner for New Genomics Research Project

February 27, 2012

Indel Therapeutics Awarded Third Patent for Novel Antimicrobial Drug Discovery Platform

December 08, 2011
Indel Therapeutics Awarded Key Patent for Novel Antimicrobial Drug Discovery Platform

April 28, 2011
Indel Raises second financing and Allan Collings joining board of directors

All rights Reserved. © 2012 Indel Therapeutics   |  Disclaimer 604.551.8464